Can a chelation treatment ease symptoms of gadolinium buildup?
NCT ID NCT06269055
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 20 times
Summary
This study looks at whether a treatment called DTPA chelation can help people with Gadolinium Deposition Disease (GDD), a condition caused by gadolinium from MRI contrast dyes staying in the body. About 50 adults with GDD will receive at least 5 sessions of two-day chelation therapy. Researchers will track changes in symptoms like pain and thinking problems, as well as any side effects, to see if the treatment offers meaningful relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GADOLINIUM DEPOSITION DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University Medical Center
RECRUITINGStanford, California, 94305, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.